Document is current

Any future updates will be listed below

Correction to: A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency

Crossref DOI link: https://doi.org/10.1007/s10875-026-01983-6

Published Online: 2026-02-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark